Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pathogenetic Basis of Aortopathy and Aortic Valve Disease

NCT03440697 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT03440697
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03440697 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pathogenetic Basis of Aortopathy and Aortic Valve Disease
Lead sponsor
Yale University
Phase
Observational
Overall status
Active, not recruiting
Start date
December 10, 2015
Completion date
December 31, 2030
Enrollment
3,000 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

aortic valve disease, aortopathies, arterial tortuosity syndrome, ascending aortic aneurysm, ascending aortic disease, autosomal recessive cutis laxa, bicuspid aortic valve, bicuspid aortic valve-associated aortopathy, congenital contractural arachnodactyly, descending aortic aneurysm, descending aortic disease, familial thoracic aortic aneurysm and aortic dissection, loeys-dietz syndrome, marfan syndrome, phace syndrome, shprintzen-goldberg syndrome, thoracic aortic aneurysm, thoracic aortic disease, thoracic aortic dissection, thoracic aortic rupture, turner syndrome, vascular ehlers-danlos syndrome